Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Perpetua Life is a biotechnology and longevity-focused company dedicated to developing advanced nutraceuticals and supplements aimed at slowing the aging process and enhancing human healthspan. The company's flagship product, AEON, is a comprehensive longevity complex that combines Nicotinamide Mononucleotide (NMN) with other synergistic compounds like trans-resveratrol and fisetin to boost NAD+ levels and activate sirtuins. Perpetua Life focuses on translating cutting-edge research in cellular biology into accessible consumer products that target the hallmarks of aging. Their business model centers on direct-to-consumer sales of science-backed formulations designed to support metabolic health, cognitive function, and cellular repair.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Perpetua Life.